Nidan Laboratories and Healthcare Limited is an India-based company. The Company is engaged in providing diagnostic services including pathology, radiology, cardiology, and neurology. Its laboratory tests offer a range of over 6000 clinical laboratory tests and profiles, which are used to provide diagnostic services for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease using technological advanced machines, prenatal screening, to screening for hormonal imbalance, nutritional deficiencies, and tracking lifestyle disorders. Its services include computed tomography (CT) scans, X-radiation (X-ray), pathology, cardio, magnetic resonance imaging (MRI), sonography, outpatient department (OPD) and others. Its lab tests include CT Lower Limb Arteriography And Venography, CT Whole Spine, CT Abdomen Angiography, CT Lumber Spine, CT Calcium Scoring, Dry Film D12, CT Extra Report and others.
NIDAN LABS AND HEALTH LTD Financial Highlights
- Revenue: NIDAN LABS AND HEALTH LTD reported revenue of ₹27.40 crore in FY26 vs ₹26.78 crore in FY25. It showed an increase of 2.32% on a yearly basis.
- Operating Profit: NIDAN LABS AND HEALTH LTD reported an operating profit of ₹2.44 crore in FY26 vs ₹2.76 crore in FY25. It showed a decrease of 11.59% on a year-on-year basis.
- Net Profit: NIDAN LABS AND HEALTH LTD reported a net profit of ₹1.51 crore in FY26 vs ₹1.98 crore in FY25. It showed a decrease of 23.74% on a yearly basis.
NIDAN LABS AND HEALTH LTD Quarterly Result Highlights
- NIDAN LABS AND HEALTH LTD reported revenue of ₹16.53 crore in Sep 2021, compared with ₹7.84 crore in Jun 2021, representing an increase of 110.84% on a quarter-on-quarter (QoQ) basis.
- NIDAN LABS AND HEALTH LTD reported an operating profit of ₹2.33 crore in Sep 2021, compared with ₹1.40 crore in Jun 2021, representing an increase of 66.43% on a quarter-on-quarter (QoQ) basis.
- NIDAN LABS AND HEALTH LTD reported a profit of ₹1.80 crore in Sep 2021, compared with ₹1.09 crore in Jun 2021, reflecting an increase of 65.14% on a QoQ basis.
- The earnings per share (EPS) of NIDAN LABS AND HEALTH LTD stood at ₹1.42 during Sep 2021.